< formatted article >

The Menopause Gold Rush: Profit Over Progress in Women’s Health

For decades, menopause was treated as a whispered inconvenience—a fleeting inconvenience to be endured with a sigh and a cold compress. But now, it’s the hottest trend in wellness, splashed across headlines and social feeds: celebrities sharing their hot flash confessions, influencers hawking unproven hormone "boosters," and an entire industry scrambling to monetize women’s midlife transitions.

At first glance, this feels like long-overdue recognition. After generations of being dismissed, women’s health struggles are finally getting airtime. But dig deeper, and the reality is far less empowering. Beneath the glossy packaging and viral marketing lies a far less noble motive: the menopause industry isn’t about solving problems—it’s about exploiting them.

The $24 Billion Scramble for Your Menopause

The numbers don’t lie. The menopause "market" is projected to balloon into a $24 billion industry by 2030, with investors and corporations racing to carve out their share. Supplements with dubious claims, overpriced wellness powders, and exclusive seminars led by self-proclaimed "experts" (often the same ones selling the products) are flooding the space.

This isn’t healthcare—it’s healthcare capitalism, where the bottom line eclipses real solutions. While venture capitalists and wellness gurus cash in, the systemic failures in women’s health remain unaddressed. The same medical field that once dismissed menopause as "just a phase" now sees it as a profit center.

And the irony? While companies rake in billions, real women’s health crises struggle for funding. No venture capitalist is rushing to invest in better gynecological research, accessible hormone therapy, or comprehensive menopause education. Instead, they’re betting on fear and quick fixes—because fear sells, and supplements are easier to market than systemic change.